Position in VOR
as of Mar 31, 2026
· filed Apr 21, 2026
Position Value
$208,728
New position
Shares Held
11,700
first reported quarter
Ownership
0.020%
of shares outstanding
% of Portfolio
0.57%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Cannon Global Investment Management, LLC holds $3,747,880 across 6 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
1,500 | $805,425 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,500 | $752,575 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
4,000 | $749,120 | |
| 4 | ABVX |
Abivax S.A.
|
5,300 | $706,278 | |
| 5 | INBX |
Inhibrx Biosciences, Inc.
|
5,900 | $559,025 | |
| 6 | TBPH |
Theravance Biopharma, Inc.
|
10,321 | $175,457 |
All Filings in VOR
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $208,728 | 11,700 | Shares | Sole | 2026-04-21 | |
| No filing history on record for this holder in this stock. | ||||||